Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:
in the sixth column, expiration of approval, of row 135, Pyrimethanil, the date is replaced by ‘30 June 2027’;
in the sixth column, expiration of approval, of row 164, Boscalid, the date is replaced by ‘31 March 2028’;
in the sixth column, expiration of approval, of row 187, Flutolanil, the date is replaced by ‘15 June 2027’;
in the sixth column, expiration of approval, of row 189, Fluazinam, the date is replaced by ‘30 November 2027’;
in the sixth column, expiration of approval, of row 213, Fenpyroximate, the date is replaced by ‘31 January 2028’;
in the sixth column, expiration of approval, of row 246, Pyrethrins, the date is replaced by ‘30 April 2028’;
in the sixth column, expiration of approval, of row 292, Sulphur, the date is replaced by ‘31 July 2027’;
in the sixth column, expiration of approval, of row 300, Malathion, the date is replaced by ‘15 July 2028’;
in the sixth column, expiration of approval, of row 301, Penoxsulam, the date is replaced by ‘15 May 2027’;
in the sixth column, expiration of approval, of row 302, Proquinazid, the date is replaced by ‘31 December 2027’;
in the sixth column, expiration of approval, of row 313, Pyridaben, the date is replaced by ‘31 January 2030’;
in the sixth column, expiration of approval, of row 317, 6-benzyladenine, the date is replaced by ‘15 January 2030’;
in the sixth column, expiration of approval, of row 323, Dodine, the date is replaced by ‘30 June 2028’;
in the sixth column, expiration of approval, of row 333, 1-decanol, the date is replaced by ‘30 June 2028’;
in the sixth column, expiration of approval, of row 335, Fluometuron, the date is replaced by ‘15 January 2030’;
in the sixth column, expiration of approval, of row 341, Sintofen, the date is replaced by ‘15 January 2030’;
in the sixth column, expiration of approval, of row 346, Aluminium sulfate, the date is replaced by ‘15 January 2030’.
Part B of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:
in the sixth column, expiration of approval, of row 6, Prohexadione, the date is replaced by ‘15 May 2028’;
in the sixth column, expiration of approval, of row 7, Spiroxamine, the date is replaced by ‘30 November 2029’;
in the sixth column, expiration of approval, of row 12, 1-naphthylacetamide, the date is replaced by ‘30 November 2029’;
in the sixth column, expiration of approval, of row 13, 1-naphthylacetic acid, the date is replaced by ‘30 November 2029’;
in the sixth column, expiration of approval, of row 15, Fluazifop-P, the date is replaced by ‘30 November 2029’;
in the sixth column, expiration of approval, of row 45, Eugenol, the date is replaced by ‘15 April 2028’;
in the sixth column, expiration of approval, of row 46, Geraniol, the date is replaced by ‘15 April 2028’;
in the sixth column, expiration of approval, of row 47, Thymol, the date is replaced by ‘15 April 2028’;
in the sixth column, expiration of approval, of row 51, Fluopyram, the date is replaced by ‘15 June 2028’;
in the sixth column, expiration of approval, of row 97, Pinoxaden, the date is replaced by ‘31 December 2029’.
Part E of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:
in the sixth column, expiration of approval, of row 2, Esfenvalerate, the date is replaced by ‘30 November 2029’;
in the sixth column, expiration of approval, of row 6, Prosulfuron, the date is replaced by ‘15 December 2029’.